Health Technology Net

Daré Bioscience to Host Second Quarter 2021 Financial Results and Company Update Conference Call and Webcast on August 12, 2021

Staff August 5, 2021

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

Staff August 5, 2021

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...

Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference

Staff August 5, 2021

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc. (Nasdaq: SRZN), a biotechnology company discovering and developing...

Ensysce Biosciences Announces Notice of Allowance from the U.S. Patent and Trademark Office for Patent Entitled “Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof”

Staff August 5, 2021

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...

CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

Staff August 5, 2021

ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...

CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021

Staff August 5, 2021

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...

Clubhouse Media President Chris Young Featured in Exclusive Benzinga Interview

Staff August 5, 2021

Clubhouse Media Co-Founder Discusses Company Origins, Business Model, and Strategic Path AheadLOS ANGELES, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via...

Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference

Staff August 5, 2021

BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing...

BioVie Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer’s Disease

Staff August 5, 2021

SANTA MONICA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing...

Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview

Staff August 5, 2021

- Successfully Completed IND-Enabling Studies for TARA-002 in Patients with NMIBC; On Track to Initiate Phase 1 Trial by Year-End...

Alignment Healthcare Partners With Cedars-Sinai in 2022, Adding Nearly 1,800 Providers to Its Network in Critical Los Angeles Market

Staff August 5, 2021

ORANGE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of...

Cidara Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

Staff August 5, 2021

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...

Icosavax Mourns Sudden Passing of Tadataka Yamada, M.D. Chairman of the Company’s Board of Directors

Staff August 5, 2021

SEATTLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP)...

Mesa Labs Announces First Quarter Results

Staff August 5, 2021

LAKEWOOD, Colo., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its first fiscal quarter...

Vystar Details Preliminary Plans for RxAir Spin Off as Shareholder Dividend

Staff August 5, 2021

Separation of RxAir® business offers pure-play investment opportunityVystar shareholders on the Record Date of January 5, 2022 to qualify for...

Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates

Staff August 5, 2021

• Lumos Pharma strengthens leadership team with promotion of John McKew, PhD to President, and addition of David B. Karpf,...

Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network

Staff August 5, 2021

-USA Equities Corp. Business Model and Strategic Direction Favorably Aligned with Industry Growth Drivers-West Palm Beach, FL, Aug. 05, 2021...

Health Technology Net

Did You Know?

The Case for Cardiovascular Collaboration: Why Platform Partnerships Drive Greater Practice Impact

Yonsei University Researchers Develop Deep Learning Model for Microsatellite Instability-High Tumor Prediction

AI Technology Could Dramatically Lower Lung Cancer Mortality Rates

The Relationship Between CMS Star Ratings and Financial Improvement

The Future of Ultrasound Reporting

Editor’s Picks

Being a Practice Owner Doesn’t Mean Skipping Holidays—Here’s How You Can Prepare

$35 Insulin: How The Program Came To Be, Who Did It And How Can You Use It?

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

Profound Medical Corp. Announces Upsize of Private Placement

Daré Bioscience to Host Second Quarter 2021 Financial Results and Company Update Conference Call and Webcast on August 12, 2021

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference

Ensysce Biosciences Announces Notice of Allowance from the U.S. Patent and Trademark Office for Patent Entitled “Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof”

CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021

Clubhouse Media President Chris Young Featured in Exclusive Benzinga Interview

Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference

BioVie Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer’s Disease

Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview

Alignment Healthcare Partners With Cedars-Sinai in 2022, Adding Nearly 1,800 Providers to Its Network in Critical Los Angeles Market

Cidara Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

Icosavax Mourns Sudden Passing of Tadataka Yamada, M.D. Chairman of the Company’s Board of Directors

Mesa Labs Announces First Quarter Results

Vystar Details Preliminary Plans for RxAir Spin Off as Shareholder Dividend

Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates

Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network

Therma Bright Finalizes Agreement with Afero for Its Smart-Enabled AcuVid(TM) Saliva Test

LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update

Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

Profound Medical Corp. Announces Upsize of Private Placement

Did You Know?

Editor’s Picks

Latest News

Fresh Off The press

You may have missed